These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 18074815

  • 1. [Immunomorphological characteristics and criteria for predicting gastrointestinal stromal tumors].
    Kravtsov VG, Zaĭrat'iants OV, Shirin Ch, Shakhmurov M, Shabat V, Kripshpon I, Alin A, Avinoach I, Avni J.
    Arkh Patol; 2007; 69(5):25-8. PubMed ID: 18074815
    [Abstract] [Full Text] [Related]

  • 2. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
    Liang YM, Li XH, Chen W.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 15; 88(15):1041-5. PubMed ID: 18754437
    [Abstract] [Full Text] [Related]

  • 3. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
    Chou YP, Lin JW, Wang CC, Chiu YC, Huang CC, Chuah SK, Tai MH, Yi LN, Lee CM, Changchien CS, Hu TH.
    Oncol Rep; 2008 Jan 15; 19(1):49-56. PubMed ID: 18097575
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.
    Nakamura N, Yamamoto H, Yao T, Oda Y, Nishiyama K, Imamura M, Yamada T, Nawata H, Tsuneyoshi M.
    Hum Pathol; 2005 Jul 15; 36(7):828-37. PubMed ID: 16084954
    [Abstract] [Full Text] [Related]

  • 5. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
    Meara RS, Cangiarella J, Simsir A, Horton D, Eltoum I, Chhieng DC.
    Cytopathology; 2007 Oct 15; 18(5):283-9. PubMed ID: 17883690
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
    Huang HY, Huang WW, Lin CN, Eng HL, Li SH, Li CF, Lu D, Yu SC, Hsiung CY.
    Ann Surg Oncol; 2006 Dec 15; 13(12):1633-44. PubMed ID: 17013685
    [Abstract] [Full Text] [Related]

  • 7. P53 and MIB-1 expression in gastrointestinal stromal tumor (GIST) of the stomach.
    Hata Y, Ishigami S, Natsugoe S, Nakajo A, Okumura H, Miyazono F, Matsumoto M, Hokita S, Aikou T.
    Hepatogastroenterology; 2006 Dec 15; 53(70):613-5. PubMed ID: 16995473
    [Abstract] [Full Text] [Related]

  • 8. Clinical, pathologic, and immunohistochemical characteristics of gastrointestinal stromal tumors of the colon and rectum: implications for surgical management and adjuvant therapies.
    Hassan I, You YN, Dozois EJ, Shayyan R, Smyrk TC, Okuno SH, Donohue JH.
    Dis Colon Rectum; 2006 May 15; 49(5):609-15. PubMed ID: 16552495
    [Abstract] [Full Text] [Related]

  • 9. Surgical management and clinical outcome of gastrointestinal stromal tumor of the colon and rectum.
    Chen CW, Wu CC, Hsiao CW, Fang FC, Lee TY, Che FC, Tsai WC, Jao SW.
    Z Gastroenterol; 2008 Aug 15; 46(8):760-5. PubMed ID: 18759198
    [Abstract] [Full Text] [Related]

  • 10. Increased cyclin D3 expression significantly correlates with p27 nuclear positivity in gastrointestinal stromal tumors.
    Draper N, Bui M, Boulware DC, Lloyd M, Chiappori AA, Pledger WJ, Coppola D.
    Hum Pathol; 2008 Dec 15; 39(12):1784-91. PubMed ID: 18701138
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M, Sobin LH, Lasota J.
    Am J Surg Pathol; 2009 Sep 15; 33(9):1267-75. PubMed ID: 19440146
    [Abstract] [Full Text] [Related]

  • 14. Prognosis of gastrointestinal stromal tumors.
    Bertin M, Angriman I, Scarpa M, Mencarelli R, Ranzato R, Ruffolo C, Polese L, Iacobone M, D'Amico DF.
    Hepatogastroenterology; 2007 Sep 15; 54(73):124-8. PubMed ID: 17419245
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gastrointestinal stromal tumors: actin expression, a new prognostic factor?
    Ruiz-Tovar J, Diez-Tabernilla M, Housari G, Martinez-Molina E, Sanjuanbenito A.
    Am Surg; 2010 Nov 15; 76(11):1244-50. PubMed ID: 21140693
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
    Boonkitticharoen V, Kulapaditharom B, Leopairut J, Kraiphibul P, Larbcharoensub N, Cheewaruangroj W, Chintrakarn C, Pochanukul L.
    Arch Otolaryngol Head Neck Surg; 2008 Dec 15; 134(12):1305-11. PubMed ID: 19075127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.